Find Comparable ETFs for ALPS Medical Breakthroughs ETF
ALPS Medical Breakthroughs ETF
SBIO - PCXSPDR S&P Biotech ETF
XBI - PCXThe SPDR S&P Biotech ETF focuses on biotechnology companies, much like SBIO, and offers exposure to innovative medical breakthroughs and therapies.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 91%
R-squared: 82%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 5
- SBIO in XBI's comparables: No
- XBI in SBIO's comparables: Yes
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- SBIO Beta: 0.92 (Average)
- XBI Beta: 0.97 (Average)
- SBIO 200-day Volatility: 27.48%
- XBI 200-day Volatility: 23.88%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- SBIO Price vs 200-day MA: 86%
- XBI Price vs 200-day MA: 91%
Performance Comparison:
| Period | SBIO | XBI |
|---|---|---|
| Year_1 | 14% | 19% |
| Year_3 | -7% | -8% |
| Year_5 | 0% | 2% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- SBIO Dividend Yield: -1%
- XBI Dividend Yield: 0%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
iShares Biotechnology ETF
IBB - NGMThe iShares Nasdaq Biotechnology ETF includes large and small-cap biotech stocks, aligning with SBIO's focus on medical advancements.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 83%
R-squared: 69%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 5
- IBB in SBIO's comparables: Yes
- SBIO in IBB's comparables: Yes
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- IBB Beta: 0.84 (Low)
- SBIO Beta: 0.92 (Average)
- IBB 200-day Volatility: 15.85%
- SBIO 200-day Volatility: 27.48%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- IBB Price vs 200-day MA: 97%
- SBIO Price vs 200-day MA: 86%
Performance Comparison:
| Period | IBB | SBIO |
|---|---|---|
| Year_1 | 14% | 14% |
| Year_3 | -4% | -7% |
| Year_5 | 7% | 0% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: NGM vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- IBB Dividend Yield: 0%
- SBIO Dividend Yield: -1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Invesco Biotechnology & Genome ETF
PBE - PCXThe Invesco Dynamic Biotechnology & Genome ETF targets biotechnology firms involved in drug development, making it a suitable peer to SBIO.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 76%
R-squared: 58%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 5
- PBE in SBIO's comparables: Yes
- SBIO in PBE's comparables: No
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- PBE Beta: 0.87 (Average)
- SBIO Beta: 0.92 (Average)
- PBE 200-day Volatility: 16.22%
- SBIO 200-day Volatility: 27.48%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- PBE Price vs 200-day MA: 96%
- SBIO Price vs 200-day MA: 86%
Performance Comparison:
| Period | PBE | SBIO |
|---|---|---|
| Year_1 | 12% | 14% |
| Year_3 | -3% | -7% |
| Year_5 | 5% | 0% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- PBE Dividend Yield: 0%
- SBIO Dividend Yield: -1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
First Trust NYSE Arca Biotechnology Index Fund
FBT - PCX
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 70%
R-squared: 49%
This indicates a moderate positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 6
- FBT in SBIO's comparables: No
- SBIO in FBT's comparables: Yes
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- FBT Beta: 0.79 (Low)
- SBIO Beta: 0.92 (Average)
- FBT 200-day Volatility: 14.96%
- SBIO 200-day Volatility: 27.48%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- FBT Price vs 200-day MA: 104%
- SBIO Price vs 200-day MA: 86%
Performance Comparison:
| Period | FBT | SBIO |
|---|---|---|
| Year_1 | 9% | 14% |
| Year_3 | 0% | -7% |
| Year_5 | 4% | 0% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- FBT Dividend Yield: 0%
- SBIO Dividend Yield: -1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Direxion Daily S&P Biotech Bull 3X Shares
LABU - PCXThe ALPS Medical Breakthroughs ETF (SBIO) targets innovative biotech companies, aligning with LABU's focus on high-growth biotech equities.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 91%
R-squared: 82%
This indicates a strong positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 6
- LABU in SBIO's comparables: Yes
- SBIO in LABU's comparables: Yes
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- LABU Beta: 3.00 (Very High)
- SBIO Beta: 0.92 (Average)
- LABU 200-day Volatility: 72.66%
- SBIO 200-day Volatility: 27.48%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- LABU Price vs 200-day MA: 67%
- SBIO Price vs 200-day MA: 86%
Performance Comparison:
| Period | LABU | SBIO |
|---|---|---|
| Year_1 | 17% | 14% |
| Year_3 | -51% | -7% |
| Year_5 | -33% | 0% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Leveraged Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- LABU Dividend Yield: 0%
- SBIO Dividend Yield: -1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Vanguard Health Care Index Fund ETF Shares
VHT - PCXThe Vanguard Health Care ETF provides broader health care exposure, including biotech and pharmaceutical companies, similar to SBIO's investment strategy.
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 57%
R-squared: 33%
This indicates a moderate positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 1
- SBIO in VHT's comparables: No
- VHT in SBIO's comparables: Yes
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- SBIO Beta: 0.92 (Average)
- VHT Beta: 0.73 (Low)
- SBIO 200-day Volatility: 27.48%
- VHT 200-day Volatility: 10.58%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- SBIO Price vs 200-day MA: 86%
- VHT Price vs 200-day MA: 100%
Performance Comparison:
| Period | SBIO | VHT |
|---|---|---|
| Year_1 | 14% | 15% |
| Year_3 | -7% | 4% |
| Year_5 | 0% | 11% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- SBIO Dividend Yield: -1%
- VHT Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
SPDR S&P 500 ETF Trust
SPY - PCX
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 60%
R-squared: 36%
This indicates a moderate positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 0
- SBIO in SPY's comparables: No
- SPY in SBIO's comparables: No
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- SBIO Beta: 0.92 (Average)
- SPY Beta: 1.00 (Average)
- SBIO 200-day Volatility: 27.48%
- SPY 200-day Volatility: 11.69%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- SBIO Price vs 200-day MA: 86%
- SPY Price vs 200-day MA: 104%
Performance Comparison:
| Period | SBIO | SPY |
|---|---|---|
| Year_1 | 14% | 20% |
| Year_3 | -7% | 8% |
| Year_5 | 0% | 14% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Health & Biotech Equities vs Large Cap Growth Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- SBIO Dividend Yield: -1%
- SPY Dividend Yield: 1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
GraniteShares HIPS US High Income ETF
HIPS - PCX
correlation
Measures how closely the two assets' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 31%
R-squared: 10%
This indicates a weak positive relationship between the price movements of these assets.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 0
- HIPS in SBIO's comparables: No
- SBIO in HIPS's comparables: No
A high score suggests the assets are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- HIPS Beta: 1.11 (Average)
- SBIO Beta: 0.92 (Average)
- HIPS 200-day Volatility: 8.32%
- SBIO 200-day Volatility: 27.48%
A high score suggests both assets have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- HIPS Price vs 200-day MA: 99%
- SBIO Price vs 200-day MA: 86%
Performance Comparison:
| Period | HIPS | SBIO |
|---|---|---|
| Year_1 | 18% | 14% |
| Year_3 | 4% | -7% |
| Year_5 | 4% | 0% |
A high score indicates both assets are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
geo
Evaluates the geographical similarity of the assets based on country, currency, and exchange.
- Currency: USD vs USD
- Exchange: PCX vs PCX
A high score indicates that both assets operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
sector
Compares the sector, industry, and other classifications of both assets.
- ETF Category: Diversified Portfolio vs Health & Biotech Equities
A high score indicates that the assets operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends.
Partial matches are considered for more nuanced comparisons, allowing for a higher score even when classifications are not identical but closely related.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- HIPS Dividend Yield: 9%
- SBIO Dividend Yield: -1%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Loading comparable ETFs ...